Otsuka Holdings Co.,Ltd. 4578Short Interest
No institution currently reports a short position of 0.5% or more in Otsuka Holdings Co.,Ltd. (4578). The last disclosure was on 2026-04-09 (J.P. MORGAN SECURITIES PLC, 0.34%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
105 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 7 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-12-07 |
|---|---|
| Latest disclosure | 2026-04-09 (J.P. MORGAN SECURITIES PLC, 0.34%) |
| Reporting institutions | 7 firms (105 reports) |
| Peak estimated short interest | 1.41% (2019-09-27, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- J.P. MORGAN SECURITIES PLC
- Societe Generale
- JPM Securities Japan Co Ltd.
- Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
- Barclays Capital Securities Ltd
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2024-08-01 | Barclays Capital Securities Ltd | Position 2,761,607 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2024-10-18 | JPM Securities Japan Co Ltd. | Position 2,641,541 shares | Ratio 0.47% | ▼0.11% | Below 0.5% |
| 2026-04-07 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,259,279 shares | Ratio 0.41% | ▼0.11% | Below 0.5% |
| 2023-01-12 | Societe Generale | Position 2,027,852 shares | Ratio 0.36% | ▼0.14% | Below 0.5% |
| 2026-04-09 | J.P. MORGAN SECURITIES PLC | Position 1,880,621 shares | Ratio 0.34% | ▼0.23% | Below 0.5% |
| 2020-10-05 | BNP Paribas Arbitrage SNC | Position 1,083,000 shares | Ratio 0.19% | ▼0.80% | Below 0.5% |
| 2019-10-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 420,177 shares | Ratio 0.07% | ▼0.79% | Below 0.5% |
Disclosure History 105 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-04-09 | J.P. MORGAN SECURITIES PLC | Position 1,880,621 shares | Ratio 0.34% | ▼0.23% | Below 0.5% |
| 2026-04-07 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,259,279 shares | Ratio 0.41% | ▼0.11% | Below 0.5% |
| 2026-04-07 | J.P. MORGAN SECURITIES PLC | Position 3,117,121 shares | Ratio 0.57% | ▲0.28% | — |
| 2026-03-24 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,864,879 shares | Ratio 0.52% | ▲0.19% | — |
| 2025-03-26 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,707,353 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2025-03-12 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,976,453 shares | Ratio 0.53% | ▲0.18% | — |
| 2024-10-18 | JPM Securities Japan Co Ltd. | Position 2,641,541 shares | Ratio 0.47% | ▼0.11% | Below 0.5% |
| 2024-10-17 | JPM Securities Japan Co Ltd. | Position 3,259,726 shares | Ratio 0.58% | ▼0.02% | — |
| 2024-10-15 | JPM Securities Japan Co Ltd. | Position 3,360,242 shares | Ratio 0.60% | ▲0.09% | — |
| 2024-10-01 | JPM Securities Japan Co Ltd. | Position 2,885,638 shares | Ratio 0.51% | ▲0.04% | — |
| 2024-08-01 | Barclays Capital Securities Ltd | Position 2,761,607 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2024-07-31 | Barclays Capital Securities Ltd | Position 2,822,527 shares | Ratio 0.50% | ▲0.01% | — |
| 2023-04-17 | JPM Securities Japan Co Ltd. | Position 2,387,484 shares | Ratio 0.42% | ▼0.16% | Below 0.5% |
| 2023-04-13 | JPM Securities Japan Co Ltd. | Position 3,278,806 shares | Ratio 0.58% | ▲0.17% | — |
| 2023-02-10 | J.P. MORGAN SECURITIES PLC | Position 1,429,695 shares | Ratio 0.25% | ▼0.40% | Below 0.5% |
| 2023-02-02 | J.P. MORGAN SECURITIES PLC | Position 3,678,895 shares | Ratio 0.65% | ▲0.12% | — |
| 2023-01-25 | J.P. MORGAN SECURITIES PLC | Position 2,971,095 shares | Ratio 0.53% | ▲0.14% | — |
| 2023-01-12 | Societe Generale | Position 2,027,852 shares | Ratio 0.36% | ▼0.14% | Below 0.5% |
| 2023-01-11 | Societe Generale | Position 2,795,126 shares | Ratio 0.50% | ▼0.11% | — |
| 2023-01-10 | Societe Generale | Position 3,448,510 shares | Ratio 0.61% | ▲0.12% | — |
| 2022-12-28 | Societe Generale | Position 2,785,026 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2022-12-21 | Societe Generale | Position 2,794,226 shares | Ratio 0.50% | ▲0.01% | — |
| 2022-12-19 | Societe Generale | Position 2,763,626 shares | Ratio 0.49% | ▼0.06% | Below 0.5% |
| 2022-12-16 | Societe Generale | Position 3,085,426 shares | Ratio 0.55% | ▲0.06% | — |
| 2022-03-14 | JPM Securities Japan Co Ltd. | Position 2,443,732 shares | Ratio 0.43% | ▼0.11% | Below 0.5% |
| 2022-03-10 | JPM Securities Japan Co Ltd. | Position 3,043,078 shares | Ratio 0.54% | ▲0.18% | — |
| 2020-10-05 | BNP Paribas Arbitrage SNC | Position 1,083,000 shares | Ratio 0.19% | ▼0.80% | Below 0.5% |
| 2020-10-01 | BNP Paribas Arbitrage SNC | Position 5,528,639 shares | Ratio 0.99% | ▲0.23% | — |
| 2020-09-30 | BNP Paribas Arbitrage SNC | Position 4,246,400 shares | Ratio 0.76% | ▼0.21% | — |
| 2020-09-29 | BNP Paribas Arbitrage SNC | Position 5,433,400 shares | Ratio 0.97% | ▲0.22% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Carna Biosciences,Inc.4572 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAIKO PHARMACEUTICAL CO.,LTD.4574 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CanBas Co.,Ltd.4575 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| D.Western Therapeutics Institute, Inc.4576 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Daito Pharmaceutical Co.,Ltd.4577 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |